Both the EASL-EASD-EASO and Asia-Pacific Working Party guidelines suggest that CK-18 has limited ability to function as a stand-alone test for distinguishing NASH from NAFL given its modest performance [12, 14]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.